Vident Investment Advisory’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-63,822
| Closed | -$14.2M | – | 55 |
|
|
2023
Q2 | $14.2M | Sell |
63,822
-7,275
| -10% | -$1.69M | 0.49% | 41 |
|
|
2023
Q1 | $17.2M | Sell |
71,097
-1,676
| -2% | -$411K | 0.56% | 25 |
|
|
2022
Q4 | $19.1M | Buy |
72,773
+9,582
| +15% | +$2.57M | 0.72% | 20 |
|
|
2022
Q3 | $13.9M | Sell |
63,191
-4,844
| -7% | -$1.17M | 0.45% | 51 |
|
|
2022
Q2 | $16.5M | Buy |
68,035
+4,480
| +7% | +$1.1M | 0.5% | 43 |
|
|
2022
Q1 | $15.4M | Buy |
63,555
+3,438
| +6% | +$790K | 0.4% | 60 |
|
|
2021
Q4 | $13.5M | Buy |
60,117
+16,369
| +37% | +$3.45M | 0.35% | 63 |
|
|
2021
Q3 | $9.3M | Buy |
43,748
+9,529
| +28% | +$2.19M | 0.28% | 72 |
|
|
2021
Q2 | $8.34M | Buy |
34,219
+4,966
| +17% | +$1.22M | 0.25% | 71 |
|
|
2021
Q1 | $7.28M | Buy |
29,253
+3,307
| +13% | +$789K | 0.25% | 73 |
|
|
2020
Q4 | $5.96M | Buy |
25,946
+4,062
| +19% | +$937K | 0.24% | 73 |
|
|
2020
Q3 | $5.56M | Buy |
21,884
+554
| +3% | +$137K | 0.28% | 78 |
|
|
2020
Q2 | $5.03M | Buy |
21,330
+1,832
| +9% | +$418K | 0.26% | 76 |
|
|
2020
Q1 | $3.95M | Buy |
19,498
+11,179
| +134% | +$2.44M | 0.26% | 73 |
|
|
2019
Q4 | $2M | Buy |
8,319
+1,163
| +16% | +$256K | 0.12% | 255 |
|
|
2019
Q3 | $1.39M | Buy |
7,156
+1,683
| +31% | +$323K | 0.12% | 123 |
|
|
2019
Q2 | $1.01M | Sell |
5,473
-12,086
| -69% | -$2.16M | 0.08% | 173 |
|
|
2019
Q1 | $3.34M | Buy |
17,559
+10,781
| +159% | +$2.06M | 0.18% | 108 |
|
|
2018
Q4 | $1.32M | Buy |
6,778
+1,540
| +29% | +$300K | 0.07% | 356 |
|
|
2018
Q3 | $1.09M | Buy |
5,238
+3,014
| +136% | +$594K | 0.04% | 451 |
|
|
2018
Q2 | $410K | Buy |
2,224
+328
| +17% | +$58K | 0.02% | 734 |
|
|
2018
Q1 | $326K | Sell |
1,896
-1,483
| -44% | -$272K | 0.01% | 766 |
|
|
2017
Q4 | $588K | Sell |
3,379
-4,831
| -59% | -$855K | 0.03% | 506 |
|
|
2017
Q3 | $1.53M | Buy |
8,210
+454
| +6% | +$80.4K | 0.08% | 310 |
|
|
2017
Q2 | $1.34M | Buy |
7,756
+935
| +14% | +$152K | 0.11% | 288 |
|
|
2017
Q1 | $1.12M | Sell |
6,821
-1,499
| -18% | -$249K | 0.11% | 300 |
|
|
2016
Q4 | $1.22M | Buy |
8,320
+407
| +5% | +$61.3K | 0.15% | 282 |
|
|
2016
Q3 | $1.32M | Sell |
7,913
-14,995
| -65% | -$2.54M | 0.18% | 259 |
|
|
2016
Q2 | $3.48M | Sell |
22,908
-28,352
| -55% | -$4.41M | 0.49% | 22 |
|
|
2016
Q1 | $7.69K | Buy |
51,260
+32,571
| +174% | +$4.84M | 0.47% | 10 |
|
|
2015
Q4 | $3.03M | Buy |
18,689
+13,829
| +285% | +$2.17M | 0.38% | 36 |
|
|
2015
Q3 | $672K | Sell |
4,860
-11,499
| -70% | -$1.81M | 0.09% | 358 |
|
|
2015
Q2 | $2.51M | Buy |
16,359
+3,657
| +29% | +$586K | 0.33% | 50 |
|
|
2015
Q1 | $2.03M | Buy |
12,702
+4,862
| +62% | +$766K | 0.41% | 24 |
|
|
2014
Q4 | $1.25M | Buy |
+7,840
| New | +$1.22M | 0.42% | 21 |
|
Other funds holding AMGN
Vident Investment Advisory's AMGN Position: Q3 2023 in Review
Vident Investment Advisory sold out of Amgen (AMGN) in Q3 2023, closing a stake of 63,822 shares — an estimated $14.2M sold.
Vident Investment Advisory first reported a position in AMGN in Q4 2014 and held it in 35 quarters. The position peaked at $19.1M in Q4 2022. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q3 2023.
- Vident Investment Advisory reported no remaining Amgen position as of Q3 2023 after selling out during the quarter.
- Vident Investment Advisory sold 63,822 Amgen shares in Q3 2023, an estimated $14.2M.
- Vident Investment Advisory first reported a position in Amgen in Q4 2014 and held it in 35 quarters.
- Vident Investment Advisory's Amgen position peaked at $19.1M in Q4 2022.
- 2,501 funds tracked by Wall St. Rank held Amgen as of Q3 2023.
Based on Vident Investment Advisory's 13F filing for Q3 2023.